Experimental Trial Delivery

Hand untwisting a gas bottle from a rack of gas bottles

Experimental cancer portfolio

Birmingham ECMC funding facilitates the development and delivery of innovative early phase trials, supporting key posts within the Cancer Research UK Clinical Trials Unit

Birmingham ECMC Portfolio pie chartView the pie chart in a table version

Case Study: Precision Medicine

Birmingham Director Professor Gary Middleton leads the National Lung Matrix Trial, a highly innovative umbrella trial evaluating drugs targeting patients’ genetic mutations. National Lung Matrix is the largest precision medicine trial in non-small cell lung cancer globally. It is delivered nationally across the ECMC network, with seventeen ECMCs among the twenty recruiting sites.